scholarly journals Sjögren’s Syndrome as an Ocular Problem: Signs and Symptoms, Diagnosis, Treatment

2019 ◽  
Author(s):  
Dorota Kopacz ◽  
Piotr Maciejewicz
Keyword(s):  
Sjögren’S Syndrome ◽  
Sjögren's Syndrome ◽  
Signs And Symptoms ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Sjögren‘S Syndrome

Comparison of Dry Eye and Mouth Signs and Symptoms in Males and Females with Sjogren's Syndrome

2005 ◽  
Vol 3 ◽  
pp. S51
Author(s):  
Barbara Caffery ◽  
Allan Slomovic ◽  
Arthur Bookman ◽  
John Rutka ◽  
John McComb
Keyword(s):  
Sjögren’S Syndrome ◽  
Dry Eye ◽  
Sjögren's Syndrome ◽  
Signs And Symptoms ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Males And Females ◽  
Sjögren‘S Syndrome

Dry Mouth and Sjögren's Syndrome: An Overview

2016 ◽  
Vol 5 (1) ◽  
pp. 70-74 ◽  
Author(s):  
Abgeena Khan ◽  
Penelope J Shirlaw
Keyword(s):  
Sjögren’S Syndrome ◽  
Sjögren's Syndrome ◽  
Signs And Symptoms ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Dry Mouth ◽  
Dry Eyes ◽  
General Dental Practitioner ◽  
Autoimmune Condition ◽  
Sjögren‘S Syndrome

Dry mouth is a common condition presenting to a GP or general dental practitioner. The most common cause of a dry mouth is related to medication use, however patients with Sjögren's syndrome, a multisystem autoimmune condition, may present to their dentist rather than their GP complaining of dry mouth and dry eyes. This article explores the causes of dry mouth and how a patient can be investigated to find the cause of their dry mouth. An overview of Sjögren's syndrome, the relevant diagnostic criteria, presenting signs and symptoms, investigations and management principles are outlined.

scholarly journals Musculoskeletal Manifestations in Sjogren’s Syndrome

2021 ◽  
Author(s):  
Ridvan İşik ◽  
Ferhat Ege
Keyword(s):  
Sjögren’S Syndrome ◽  
Sjögren's Syndrome ◽  
Clinical Signs ◽  
Signs And Symptoms ◽  
Lymphocytic Infiltration ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Musculoskeletal Manifestations ◽  
Clinical Signs And Symptoms ◽  
Sjögren‘S Syndrome

Sjögren’s syndrome (SS) is a chronic, autoimmune, inflammatory disease characterized by lymphocytic infiltration, destruction and dysfunction of the exocrine glands. Sjögren’s syndrome can be described as primary or secondary, depending on whether it occurs alone or in association with other systemic autoimmune diseases. Systemic manifestations of SS involve the musculoskeletal system. SS can be seen in association with both joint and muscle manifestations, including arthralgia and arthritis, as well as myopathy, which is usually asymptomatic. Besides, it may include bone metabolic disorders, fatigue and fibromyalgia. The diagnosis of Sjögren’s syndrome is based on characteristic clinical signs and symptoms. The etiology and pathogenesis of SS is elusive and has not yet been clarified. There is no curative treatment for SS, thus the aim in the treatment of SS is to alleviate the symptoms.

The association of Raynaud’s phenomenon/syndrome with scleroderma and Sjögren’s syndrome – a meta-analysis

VASA ◽  
2008 ◽  
Vol 37 (Supplement 73) ◽  
pp. 26-32 ◽  
Author(s):  
Schlattmann ◽  
Höhne ◽  
Plümper ◽  
Heidrich
Keyword(s):  
Quantitative Analysis ◽  
Sjögren’S Syndrome ◽  
Mixture Model ◽  
Sjögren's Syndrome ◽  
Meta Analysis ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Raynaud’S Syndrome ◽  
Raynaud's Syndrome ◽  
Sjögren‘S Syndrome

Background: In order to analyze the prevalence of Raynaud’s syndrome in diseases such as scleroderma and Sjögren’s syndrom – a meta-analysis of published data was performed. Methods: The PubMed data base of the National Library of Medicine was used for studies dealing with Raynaud’s syndrome and scleroderma or Raynaud’s syndroem and Sjögren’s syndrom respectively. The studies found provided data sufficient to estimate the prevalence of Raynaud’s syndrome. The statistical analysis was based on methods for a fixed effects meta-analysis and finite mixture model for proportions. Results: For scleroderma a pooled prevalence of 80.9% and 95% CI (0.78, 0.83) was obtained. A mixture model analysis found four latent classes. We identified a class with a very low prevalence of 11%, weighted with 0.15. On the other hand there is a class with a very high prevalence of 96%. Analysing the association with Sjögren’s syndrome, the pooled analysis leads to a prevalence of Raynaud’s syndrome of 32%, 95% CI(26.7%, 37.7%). A mixture model finds a solution with two latent classes. Here, 38% of the studies show a prevalence of 18.8% whereas 62% observe a prevalence of 38.3%. Conclusion: There is strong variability of studies reporting the prevalence of Raynaud’s syndrome in patients suffering from scleroderma or Sjögren’s syndrome. The available data are insufficient to perform a proper quantitative analysis of the association of Raynaud’s phenomenon with scleroderma or Sjögren’s syndrome. Properly planned and reported epidemiological studies are needed in order to perform a thorough quantitative analysis of risk factors for Raynaud’s syndrome.

A Case of Primary Sjögren's Syndrome with Cutaneous Vasculopathy Presenting as Leg Ulcers

2006 ◽  
Vol 68 (6) ◽  
pp. 626-629
Author(s):  
Akihiro SOTOME ◽  
Youichiro HAMASAKI ◽  
Yohei KITAMURA ◽  
Yumi KAWAHARA ◽  
Sityu HOU ◽  
...  
Keyword(s):  
Sjögren’S Syndrome ◽  
Sjögren's Syndrome ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Primary Sjögren’S Syndrome ◽  
Leg Ulcers ◽  
Primary Sjogren’S Syndrome ◽  
Primary Sjögren's Syndrome ◽  
Sjögren‘S Syndrome
Sign in / Sign up

Export Citation Format

Share Document